#lung cancer

First-Line Immunotherapy Combo Slows Lung Cancer Progression

Immunotherapy combo leads to longer progression-free survival.

Nancy Hale participated in a clinical trial and saw incredible results.

Immunotherapy worked better than chemotherapy as first-line treatment for people with a favorable biomarker.

The fall was largely as a result of declines in breast, colon, lung and prostate cancers.

Checkpoint inhibitors can restore T-cell activity, but they don’t work for everyone.

How an unexpected lung cancer diagnosis reshaped Laura Greco’s world

A new therapy, BLU-667, shows broad antitumor activity against cancers with a variety of RET alterations.

Stigma affects access to treatment, research funding, public empathy and support for all people with lung cancer.

In every issue of Cancer Health, you’ll find cutting-edge health information and the hottest topics of interest to people with cancer and th...

LOXO-292 demonstrates durable antitumor activity in people with lung, thyroid and other cancers.

Smoking behaviors do not explain this new finding.

Smokers in particular would reduce their risk of death similarly through such screening.

Novel UCSF project finds social media treatment can be effective even for those not ready to quit.

While cancer risk decreases steadily but slowly after quitting smoking, the risks for heart attack and stroke decline much more rapidly.

As the lung cancer community and the lung cancer movement grew, the awareness activities increased